Claro Advisors LLC Raises Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Claro Advisors LLC grew its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 67.2% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 10,493 shares of the healthcare conglomerate’s stock after purchasing an additional 4,219 shares during the quarter. UnitedHealth Group makes up 0.9% of Claro Advisors LLC’s investment portfolio, making the stock its 21st largest holding. Claro Advisors LLC’s holdings in UnitedHealth Group were worth $5,191,000 as of its most recent SEC filing.

Other institutional investors also recently added to or reduced their stakes in the company. Miracle Mile Advisors LLC grew its stake in shares of UnitedHealth Group by 4.4% during the 1st quarter. Miracle Mile Advisors LLC now owns 26,100 shares of the healthcare conglomerate’s stock worth $12,912,000 after acquiring an additional 1,095 shares during the period. Little House Capital LLC increased its stake in shares of UnitedHealth Group by 33.2% in the first quarter. Little House Capital LLC now owns 11,595 shares of the healthcare conglomerate’s stock worth $5,736,000 after purchasing an additional 2,888 shares in the last quarter. Horizon Wealth Management LLC lifted its stake in shares of UnitedHealth Group by 4.5% during the 1st quarter. Horizon Wealth Management LLC now owns 1,177 shares of the healthcare conglomerate’s stock valued at $582,000 after buying an additional 51 shares in the last quarter. BKM Wealth Management LLC grew its stake in UnitedHealth Group by 34.7% in the 1st quarter. BKM Wealth Management LLC now owns 5,157 shares of the healthcare conglomerate’s stock valued at $2,551,000 after buying an additional 1,328 shares in the last quarter. Finally, Diversified Trust Co lifted its position in shares of UnitedHealth Group by 2.3% during the first quarter. Diversified Trust Co now owns 44,775 shares of the healthcare conglomerate’s stock worth $22,151,000 after acquiring an additional 1,021 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Down 2.9 %

NYSE UNH opened at $494.43 on Tuesday. The stock has a 50-day moving average of $498.34 and a 200-day moving average of $501.63. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.69. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $554.70. The firm has a market cap of $455.07 billion, a PE ratio of 30.22, a price-to-earnings-growth ratio of 1.48 and a beta of 0.60.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.63 by $0.28. The firm had revenue of $99.80 billion for the quarter, compared to analysts’ expectations of $99.23 billion. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The business’s revenue was up 8.6% on a year-over-year basis. During the same quarter last year, the business earned $6.26 earnings per share. As a group, sell-side analysts forecast that UnitedHealth Group Incorporated will post 27.55 EPS for the current year.

UnitedHealth Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, June 25th. Shareholders of record on Monday, June 17th were issued a $2.10 dividend. The ex-dividend date was Monday, June 17th. This represents a $8.40 annualized dividend and a yield of 1.70%. This is a boost from UnitedHealth Group’s previous quarterly dividend of $1.88. UnitedHealth Group’s dividend payout ratio (DPR) is 51.34%.

Analyst Ratings Changes

A number of analysts recently issued reports on UNH shares. Royal Bank of Canada dropped their price objective on UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating on the stock in a report on Wednesday, April 17th. JPMorgan Chase & Co. boosted their price objective on shares of UnitedHealth Group from $546.00 to $559.00 and gave the company an “overweight” rating in a research note on Thursday, May 30th. Baird R W raised shares of UnitedHealth Group to a “strong-buy” rating in a report on Thursday, May 30th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $591.00 price objective on shares of UnitedHealth Group in a research report on Wednesday, June 12th. Finally, Deutsche Bank Aktiengesellschaft upped their target price on UnitedHealth Group from $545.00 to $562.00 and gave the stock a “buy” rating in a research note on Friday, April 19th. Three research analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and an average target price of $579.74.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.